Expression of α-Fetoprotein and Prostate-specific Antigen Genes in Several Tissues and Detection of mRNAs in Normal Circulating Blood by Reverse Transcriptase-Polymerase Chain Reaction

Japanese Journal of Clinical Oncology

Volumn 28, Issue 12, 1998, Pages 723-728

  Ishikawa, Tomoyoshi ^a   Kashiwagi, Hironobu ^a   Iwakami, Yoko ^a   Hirai, Misako ^a   Kawamura, Tomonori ^a   Aiyoshi, Yuji ^a   Yashiro, Toru ^a   Ami, Yoshihiro ^b   Uchida, Kazuhiko ^a   Miwa, Masanao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Department of Urology Tsukuba Gakuen Hospital   (Japan)

Author keywords

Molecular diagnosis; Prostate specific antigen; Reverse transcriptase polymerase chain reaction; Tissue specific expression; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT TUMOR; BLADDER TUMOR; BLOOD; CHEMISTRY; FETUS; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; PANCREAS TUMOR; PLEOMORPHIC ADENOMA; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR; TRANSITIONAL CELL CARCINOMA;

ADENOMA, PLEOMORPHIC; ADULT; ALPHA-FETOPROTEINS; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, TRANSITIONAL CELL; FETUS; HUMANS; LIVER NEOPLASMS; MALE; PANCREATIC NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0032253130     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.12.723     Document Type: Article

References (35)

1. Health and Welfare Statistics Association. Kouseinoshihyou, Kokumineiseino-Doukou 1997;44:48-61 (in Japanese).
2. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
3. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
4. Kirsch JA, Wise RW, Oilver IT Post-albumin, a fetal-specific rat plasma protein. Purification, physicochemical and immunological studies. Biochem J 1967;102:763-6
5. Ruoslahti E, Seppala M, Pikko M, Vuopio R. Studies of carcino-fetal proteins. II. Biochemical comparison of α-fetoprotein from human fetuses and patients with hepatocellular cancer. Int. J. Cancer 1971;8:283-8.
6. 1 protein in developing mice and murine hepatomas and teratomas. Cancer Res 1971;31:930-6.
7. Branch WR, Wild AE. Localization and synthesis of α-fetoprotein in the rabbit. Z Zellforsch Mikrosk Anal 1972;135:501-16.
8. Tamaoki T, Thomas K, Schindler I. Cell-free studies of developmental changes in synthesis of α-fetoprotein and albumin in the mouse liver Nature 1974;249:269-71
9. Wang MC, Papsidero LD, Kuriyama M, Valenzuela LA, Murphy GP, Chu TM. prostate antigen:a new potential marker for prostatic cancer. Prostate 1981;2:89-96.
10. Watt KWK, Lee PJ, M'Timkulu T, Chan WP, Loor R. Human prostate-specific antigen, structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986;83:3166-70.
11. Henttu P, Liao S, Vihko P. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 1992;130:766-72.
12. Katz AE, Seaman ES, Olsson CA, O'Toole KM, Raffo AJ, McMahon D, et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994;43:765-75.
13. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128-32.
14. Funaki N, Tanaka J, Seto S, Kasamatsu T, Kaido T, Imamura M. Highly-sensitive identification of α-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients. Life Sci 1995;57:1621-31.
15. Louha M, Poussin K, Ganne N, Zylberberg H, Nalpas B, Nicolet J, et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997;26:998-1005.
16. Kawakami M, Okaneya T, Furihata K, Nishizawa O, Katsuyama T. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res 1997;57:4167-70.
17. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1994;12:2634-9.
18. Israeli RS, Miller WH, Su SL, Powell CT, Fair WR, Samadi DS, et al. Sensitive nested reverse transcriptase polymerase chain reaction detection of circulating prostate tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 1994;54:6306-10.
19. Ennis RD, Katz AE, de Vries GM, Heitjan DF, O'Toole KM, Rubin M, et al. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics. Cancer 1997;79:2402-8.
20. Johnson PWM, Burchill SA, Selby PJ. The molecular detection of circulating tumour cells Br J Cancer 1995;72:268-76.
21. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, et al. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995;55:2104-10.
22. Lehrer S, Terk M, Piccoli SP, Song HK, Lavagnim P, Luderer AA. Reverse transcriptase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 1996;74:871-3.
23. Bilgrami S, Singh NT, Shafi N, Ciesielski T. Raised prostate-specific antigen in adenocarcinoma of lung. Lancet 1994;344:1371-2.
24. Yu H, Diamandis EP, Levesque MA, Asa S, Monne M, Croce CM. Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res 1995;55:1603-6.
25. Levesque M, Yu H, D'Costa M, Diamandis EP. Prostate specific antigen expression by various tumors. J Clin Lab Anal 1995;9:123-8.
26. Gilbert JC, Chiu J-F. Tissue specific control of α-fetoprotein gene expression. Biochem Biophys Res Commun 1984;120:677-85.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
28. Hayakawa S, Saito S, Nemoto N, Chishima F, Akiyama K, Shiraishi H, et al. Expression of recombinase-activating genes (RAG-1 and 2) in human decidual mononuclear cells. J Immunol 1994;153:4934-9
29. Kamoshida S, Tsutsumi Y. Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990;21:1108-11.
30. Iwakiri J, Grandbois K, Wehner N, Graves HCB, Stamey T. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J Urol 1993;149:783-6.
31. Van Krieken TH. Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry. Am J Surg Pathol 1990;17:410-4.
32. Wernett N, Albrech M, Sesterhum I, Goebbels R, Bonkhoff H, Seiz G, et al. The 'female prostate': location, morphology, immunohistochemical characteristics and significance. Eur Urol 1992;17:64-9.
33. Zarghami N, D'Costa M, Tsuyuki D, Asa SL, Diamandis EP. Expression of the prostate specific antigen gene by lung tissue. Clin Cancer Res 1997;3:1201-6.
34. Clements J, Mukhtar A. Glamdular kallikreins and prostate-specific antigen are expressed in human endometrium. J Clin Endocrinol Metab 1994;78:1536-9.
35. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP. Immunoreactive prostate specific antigen in lung tumors. J Clin Lab Anal 1995;9:375-9.